215 related articles for article (PubMed ID: 20890933)
21. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
[TBL] [Abstract][Full Text] [Related]
22. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
Zhang G; Qin L; Shi Y
J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
[TBL] [Abstract][Full Text] [Related]
23. Effect of dietary supplementation with collagen hydrolysates on bone metabolism of postmenopausal women with low mineral density.
Cúneo F; Costa-Paiva L; Pinto-Neto AM; Morais SS; Amaya-Farfan J
Maturitas; 2010 Mar; 65(3):253-7. PubMed ID: 19892499
[TBL] [Abstract][Full Text] [Related]
24. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
[No Abstract] [Full Text] [Related]
25. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
Matsumoto T; Miki T; Hagino H; Sugimoto T; Okamoto S; Hirota T; Tanigawara Y; Hayashi Y; Fukunaga M; Shiraki M; Nakamura T
J Clin Endocrinol Metab; 2005 Sep; 90(9):5031-6. PubMed ID: 15972580
[TBL] [Abstract][Full Text] [Related]
26. 2MD, a new anabolic agent for osteoporosis treatment.
Plum LA; Fitzpatrick LA; Ma X; Binkley NC; Zella JB; Clagett-Dame M; DeLuca HF
Osteoporos Int; 2006; 17(5):704-15. PubMed ID: 16491322
[TBL] [Abstract][Full Text] [Related]
27. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
[TBL] [Abstract][Full Text] [Related]
28. Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation.
Grados F; Brazier M; Kamel S; Mathieu M; Hurtebize N; Maamer M; Garabédian M; Sebert JL; Fardellone P
J Clin Endocrinol Metab; 2003 Nov; 88(11):5175-9. PubMed ID: 14602746
[TBL] [Abstract][Full Text] [Related]
29. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
Saito H; Takeda S; Amizuka N
J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
[TBL] [Abstract][Full Text] [Related]
30. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
Macdonald HM; Wood AD; Aucott LS; Black AJ; Fraser WD; Mavroeidi A; Reid DM; Secombes KR; Simpson WG; Thies F
J Bone Miner Res; 2013 Oct; 28(10):2202-13. PubMed ID: 23585346
[TBL] [Abstract][Full Text] [Related]
31. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.
Horwitz MJ; Augustine M; Khan L; Martin E; Oakley CC; Carneiro RM; Tedesco MB; Laslavic A; Sereika SM; Bisello A; Garcia-Ocaña A; Gundberg CM; Cauley JA; Stewart AF
J Bone Miner Res; 2013 Nov; 28(11):2266-76. PubMed ID: 23661240
[TBL] [Abstract][Full Text] [Related]
32. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up.
Pavón de Paz I; Rosado Sierra JA; Pérez Blanco C; Modroño Móstoles N; Guijarro de Armas G; Navea Aguilera C
Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):108-116. PubMed ID: 30077631
[TBL] [Abstract][Full Text] [Related]
33. POTASSIUM CITRATE DECREASES BONE RESORPTION IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL.
Gregory NS; Kumar R; Stein EM; Alexander E; Christos P; Bockman RS; Rodman JS
Endocr Pract; 2015 Dec; 21(12):1380-6. PubMed ID: 26401577
[TBL] [Abstract][Full Text] [Related]
34. A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
Halse J; Greenspan S; Cosman F; Ellis G; Santora A; Leung A; Heyden N; Samanta S; Doleckyj S; Rosenberg E; Denker AE
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2207-15. PubMed ID: 25166719
[TBL] [Abstract][Full Text] [Related]
35. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Massa A; Baldini N
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30213095
[TBL] [Abstract][Full Text] [Related]
36. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
Kubodera N; Tsuji N; Uchiyama Y; Endo K
J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
[TBL] [Abstract][Full Text] [Related]
37. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial.
Vallibhakara SA; Nakpalat K; Sophonsritsuk A; Tantitham C; Vallibhakara O
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959779
[TBL] [Abstract][Full Text] [Related]
38. Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia.
Filip R; Possemiers S; Heyerick A; Pinheiro I; Raszewski G; Davicco MJ; Coxam V
J Nutr Health Aging; 2015 Jan; 19(1):77-86. PubMed ID: 25560820
[TBL] [Abstract][Full Text] [Related]
39. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.
Spector TD; Calomme MR; Anderson SH; Clement G; Bevan L; Demeester N; Swaminathan R; Jugdaohsingh R; Berghe DA; Powell JJ
BMC Musculoskelet Disord; 2008 Jun; 9():85. PubMed ID: 18547426
[TBL] [Abstract][Full Text] [Related]
40. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
